Department of Antiviral Research, Department of Drug Metabolism and Pharmacokinetics, Department of Structural Biology, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, IL 60064, USA
Abstract:
A series of quinoline derivatives was synthesized as potential bioisosteric replacements for the benzothiadiazine moiety of earlier Hepatitis C NS5B polymerase inhibitors. Several of these compounds exhibited potent activity in enzymatic and replicon assays.